Use of fluorescent in situ hybridization for marker chromosome identification in congenital and neoplastic disorders

C. R. Schad, W. J. Kraker, S. M. Jalal, M. S. Tallman, H. N. Londer, L. P. Cook, Robert Brian Jenkins

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Identifying marker chromosomes of unknown origin in the clinical cytogenetics laboratory has been a problem historically, despite advances in specialized staining techniques. Determination of the origin of these marker chromosomes in patients with congenital or malignant neoplastic disorders is essential for more complete diagnosis, counseling, and treatment. The authors describe the use of fluorescent in situ hybridization with chromosome-specific alpha-satellite DNA probes to identify the origin of marker chromosomes in two patients with congenital disorders and three patients with malignant neoplastic disorders. The impact of firm identification of the marker chromosome for the diagnosis of these patients is discussed. The authors also discuss the feasibility of using this technique routinely in the clinical cytogenetics laboratory.

Original languageEnglish (US)
Pages (from-to)203-210
Number of pages8
JournalAmerican Journal of Clinical Pathology
Volume96
Issue number2
StatePublished - 1991

Fingerprint

Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Fluorescence In Situ Hybridization
Genetic Markers
Cytogenetics
Satellite DNA
DNA Probes
Counseling
Chromosomes
Staining and Labeling
Therapeutics

Keywords

  • Congenital disorders
  • Hematologic disorders
  • In situ hybridization
  • Marker chromosome identification

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Use of fluorescent in situ hybridization for marker chromosome identification in congenital and neoplastic disorders. / Schad, C. R.; Kraker, W. J.; Jalal, S. M.; Tallman, M. S.; Londer, H. N.; Cook, L. P.; Jenkins, Robert Brian.

In: American Journal of Clinical Pathology, Vol. 96, No. 2, 1991, p. 203-210.

Research output: Contribution to journalArticle

Schad, C. R. ; Kraker, W. J. ; Jalal, S. M. ; Tallman, M. S. ; Londer, H. N. ; Cook, L. P. ; Jenkins, Robert Brian. / Use of fluorescent in situ hybridization for marker chromosome identification in congenital and neoplastic disorders. In: American Journal of Clinical Pathology. 1991 ; Vol. 96, No. 2. pp. 203-210.
@article{5f862c58c0af48119af6a925d6bd9719,
title = "Use of fluorescent in situ hybridization for marker chromosome identification in congenital and neoplastic disorders",
abstract = "Identifying marker chromosomes of unknown origin in the clinical cytogenetics laboratory has been a problem historically, despite advances in specialized staining techniques. Determination of the origin of these marker chromosomes in patients with congenital or malignant neoplastic disorders is essential for more complete diagnosis, counseling, and treatment. The authors describe the use of fluorescent in situ hybridization with chromosome-specific alpha-satellite DNA probes to identify the origin of marker chromosomes in two patients with congenital disorders and three patients with malignant neoplastic disorders. The impact of firm identification of the marker chromosome for the diagnosis of these patients is discussed. The authors also discuss the feasibility of using this technique routinely in the clinical cytogenetics laboratory.",
keywords = "Congenital disorders, Hematologic disorders, In situ hybridization, Marker chromosome identification",
author = "Schad, {C. R.} and Kraker, {W. J.} and Jalal, {S. M.} and Tallman, {M. S.} and Londer, {H. N.} and Cook, {L. P.} and Jenkins, {Robert Brian}",
year = "1991",
language = "English (US)",
volume = "96",
pages = "203--210",
journal = "American Journal of Clinical Pathology",
issn = "0002-9173",
publisher = "American Society of Clinical Pathologists",
number = "2",

}

TY - JOUR

T1 - Use of fluorescent in situ hybridization for marker chromosome identification in congenital and neoplastic disorders

AU - Schad, C. R.

AU - Kraker, W. J.

AU - Jalal, S. M.

AU - Tallman, M. S.

AU - Londer, H. N.

AU - Cook, L. P.

AU - Jenkins, Robert Brian

PY - 1991

Y1 - 1991

N2 - Identifying marker chromosomes of unknown origin in the clinical cytogenetics laboratory has been a problem historically, despite advances in specialized staining techniques. Determination of the origin of these marker chromosomes in patients with congenital or malignant neoplastic disorders is essential for more complete diagnosis, counseling, and treatment. The authors describe the use of fluorescent in situ hybridization with chromosome-specific alpha-satellite DNA probes to identify the origin of marker chromosomes in two patients with congenital disorders and three patients with malignant neoplastic disorders. The impact of firm identification of the marker chromosome for the diagnosis of these patients is discussed. The authors also discuss the feasibility of using this technique routinely in the clinical cytogenetics laboratory.

AB - Identifying marker chromosomes of unknown origin in the clinical cytogenetics laboratory has been a problem historically, despite advances in specialized staining techniques. Determination of the origin of these marker chromosomes in patients with congenital or malignant neoplastic disorders is essential for more complete diagnosis, counseling, and treatment. The authors describe the use of fluorescent in situ hybridization with chromosome-specific alpha-satellite DNA probes to identify the origin of marker chromosomes in two patients with congenital disorders and three patients with malignant neoplastic disorders. The impact of firm identification of the marker chromosome for the diagnosis of these patients is discussed. The authors also discuss the feasibility of using this technique routinely in the clinical cytogenetics laboratory.

KW - Congenital disorders

KW - Hematologic disorders

KW - In situ hybridization

KW - Marker chromosome identification

UR - http://www.scopus.com/inward/record.url?scp=0026350942&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026350942&partnerID=8YFLogxK

M3 - Article

C2 - 1862775

AN - SCOPUS:0026350942

VL - 96

SP - 203

EP - 210

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

IS - 2

ER -